Bing Guan

Bing Guan


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2023 in Frontiers in Drug Delivery
Verified
Journal Article
Open access
XZXu Zhang
Xu Zhang
MWMaohua Wang
Maohua Wang
ZLZhixian Liu
Zhixian Liu
YWYing Wang
Ying Wang
BGBing Guan
Bing Guan
BGBing Guan
Bing Guan
Neurodegenerative diseases (NDs) have become a serious global health problem as the population ages. Traditionally, treatment strategies for NDs have included oral and intravenous administration; however, the blood–brain barrier (BBB) can prevent drugs from reaching the brain, rendering the treatment incomplete and the effect unsatisfactory. Additionally, the prolonged or excessive use of drugs that can cross the BBB can damage liver and kidney function. Recent studies have shown that nose-to-brain drug delivery can noninvasively bypass the BBB, allowing drugs to enter the brain through the olfactory or trigeminal nerve pathways; additionally, nanoparticle carriers can enhance drug delivery. This review introduces drug carrier nanoparticles for nose-to-brain delivery systems, compares the advantages and disadvantages of different nanoparticles, and discusses the factors influencing nose-to-brain nanomedicine delivery and enhancement strategies. We also summarize nose-to-brain delivery and nanomedicines for treating NDs, the current challenges of this approach, and the future promise of nanomedicine-based ND treatment.

18 October 2023 in Immunity, Inflammation and Disease
Verified
Journal Article
Open access
XZXu Zhang
Xu Zhang
BGBing Guan
Bing Guan
BGBing Guan
Bing Guan
Background: The etiology and pathophysiological mechanisms of sudden sensorineural hearing loss (SSNHL) remain unclear, but it is generally believed to be associated with viral infections, vascular diseases, and autoimmune disorders. Considering that coronavirus disease 2019 (COVID‐19) is promising candidates for SSNHL, we studied the immune cells changes by COVID‐19 in patients with SSNHL.Methods: We collected data from 47 patients with SSNHL and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) positive. Patients were divided into ineffective or effective groups based on the degree of hearing recovery at discharge. Clinical information was collected and processed for both groups. Logistic regression models were used to determine the risk factors for an unfavorable prognosis in COVID‐19‐related SSNHL. Receiver operating characteristic (ROC) curves were used to estimate the predictive value.Results: There was statistically significant difference in C‐reactive protein (CRP), auditory curve, degree decline, pretreatment hearing, posttreatment hearing, systolic blood pressure, diastolic blood pressure, total bilirubin, neutrophil‐to‐lymphocyte ratio (NLR), systemic immune‐inflammation index (SII), indirect‐bilirubin and platelet count between groups (p < 0.05). In the logistic regression model, high levels of SII and NLR were associated with treatment ineffectiveness, pre‐ and postcorrectively (both, p < 0.05). And ROC curve analysis showed higher AUC of 0.765 for SII, 0.697 for NLR,0.681 for CRP, and 0.553 for platelet‐to‐lymphocyte ratio (PLR) in predicting treatment outcomes.Conclusion: The prognosis of COVID‐19‐related SSNHL was associated with inflammation. SII, NLR and CRP could serve as predictive markers of unfavorable outcomes in COVID‐19‐related SSNHL. SII may be considered an independent risk factor for poor prognosis in COVID‐19‐related SSNHL.

12 September 2022 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
BGBing Guan
Bing Guan
MWMaohua Wang
Maohua Wang
ZZZhenhua Zhong
Zhenhua Zhong
BLBaoxu Liu
Baoxu Liu
WZWentao Zhang
Wentao Zhang
BGBing Guan
Bing Guan
Pharyngocutaneous fistula is the most common complication after total laryngectomy and is difficult to heal. Although conservative treatment and surgical repair are effective, they often take longer and additional trips to the operating room, which undoubtedly increases the financial burden on patients. Especially in combination with diseases such as diabetes and hypertension, which affect the efficacy of surgery. Adding growth factors into the repair material can promote fibroblast proliferation, angiogenesis, and accelerate wound healing. A substantial number of studies have shown that a type of nanoscale extracellular vesicle, called exosomes, facilitates organization repair by promoting blood vessel production, protein polysaccharides, and collagen deposition, thereby representing a new type of cellular therapy. At present, there is little research on the application of exosomes in pharyngocutaneous fistula regeneration after total laryngectomy. In this review, we summarize the biological characteristics of exosomes and their application in biomedical science, and highlight their application prospects in pharyngocutaneous fistula regeneration after total laryngectomy.